These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


365 related items for PubMed ID: 23295955

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development.
    Tedeschi PM, Vazquez A, Kerrigan JE, Bertino JR.
    Mol Cancer Res; 2015 Oct; 13(10):1361-6. PubMed ID: 26101208
    [Abstract] [Full Text] [Related]

  • 23. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    Fang XJ, Jiang H, Zhao XP, Jiang WM.
    BMC Cancer; 2011 Jul 12; 11():290. PubMed ID: 21749678
    [Abstract] [Full Text] [Related]

  • 24. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
    Xiao M, Yang S, Meng F, Qin Y, Yang Y, Jia S, Cai X, Li C, Huang Y, Ning X.
    Cell Physiol Biochem; 2017 Jul 12; 41(3):1072-1082. PubMed ID: 28245476
    [Abstract] [Full Text] [Related]

  • 25. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C, Li M, Guo T, Wang S, Huang W, Yang K, Liao Z, Wang J, Zhang F, Wang H.
    Phytomedicine; 2019 May 12; 58():152740. PubMed ID: 31005718
    [Abstract] [Full Text] [Related]

  • 26. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF, Tascón R, Lago Huvelle MR, Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM, Bal de Kier Joffé E, Labriola L, Peters MG.
    Oncotarget; 2016 Sep 13; 7(37):60133-60154. PubMed ID: 27507057
    [Abstract] [Full Text] [Related]

  • 27. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J, Liang S, Duan X.
    J Cell Biochem; 2019 Jun 13; 120(6):9539-9546. PubMed ID: 30525231
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T, Nyarko JN, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD.
    Cell Signal; 2014 Dec 13; 26(12):2621-32. PubMed ID: 25152370
    [Abstract] [Full Text] [Related]

  • 33. Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells.
    Fuh KF, Shepherd RD, Withell JS, Kooistra BK, Rinker KD.
    Breast Cancer Res; 2021 Oct 12; 23(1):97. PubMed ID: 34641959
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
    Chen J, Li N, Liu B, Ling J, Yang W, Pang X, Li T.
    Life Sci; 2020 May 01; 248():117469. PubMed ID: 32109485
    [Abstract] [Full Text] [Related]

  • 37. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L, Sun JJ, Cui YC, Jiang SL, Wang XW, Lv LY, Xie L, Song XR.
    Tumour Biol; 2016 Jul 01; 37(7):9979-87. PubMed ID: 26819207
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
    Hiscox S, Baruha B, Smith C, Bellerby R, Goddard L, Jordan N, Poghosyan Z, Nicholson RI, Barrett-Lee P, Gee J.
    BMC Cancer; 2012 Oct 06; 12():458. PubMed ID: 23039365
    [Abstract] [Full Text] [Related]

  • 39. [Transmembrane prostate androgen-induced protein 1 (PMEPA1) promotes the migration and maintains mesenchymal-like phenotype of breast cancer cells].
    Zou Y, Zhang Y, Wang T, Wang S, Yang A, Jia L, Wang L.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb 06; 32(2):158-62. PubMed ID: 26927372
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.